Literature DB >> 191347

Fine structural studies of a human thyroid adenoma, with special reference to psammoma bodies.

J L Olson, D P Penney, K A Averill.   

Abstract

The fine structural morphologic features of a microfollicular thyroid adenoma from a 28 year old female were examined. Although the patient had been laking exogenous thyroxine therapy for 14 months, the morphology of the adenoma was characterized by numerous small to medium sized follicles composed of metabolically active, well differentiated columnar cells with numerous colloid droplets, dilated granular endoplasmic reticulum, large numbers of coated vesicles and lysosomes, large colloid containing "lakes," microtubules, microfilaments, and prominent apical microvillous projections. Of special inetrest were small spherical psammomatous calcospherites ecountered in histiocytes and the interstitium. Also noteworthy were ropelike configurations observed in most of the follicular lumina. Structural-functional correlations and potential origins of psammoma bodies and calcospherites are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191347     DOI: 10.1016/s0046-8177(77)80070-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Formation of psammoma bodies in meningocytic whorls. Ultrastructural study and analysis of calcified material.

Authors:  T Kubota; T Yamashima; M Hasegawa; S Kida; M Hayashi; S Yamamoto
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Fine structure of psammoma bodies at the outer aspect of blood vessels in meningioma.

Authors:  T Kubota; A Hirano; K Sato; S Yamamoto
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

3.  Computerized tomography findings in calcified signet-ring gastric cancer receiving chemotherapy: a case report.

Authors:  Ting Wang; Zhi-Yong Lu; Xin-Fei Tu; Shui-Hong Zhang; Fang Huang; Long Huang
Journal:  BMC Cancer       Date:  2018-04-27       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.